Latest Post

Solazyme still faces production challenges at Moema

Solazyme still faces production challenges at Moema

I wonder how long the petrochemical industry had perfected its processing technologies before it was able to reach an economical, efficient level? Unfortunately, investors today are not too forgiving when new, untested technologies from public companies are facing commercialization challenges. Solazyme is now going through this stage and their stocks had plunged from $11.79 a … Continue reading »

Enter your email address to follow this blog and receive notifications of new posts by email.

SUBSCRIBE TO BIO-MATERIALS NEWSLETTER

ADVERTISEMENT

Archives

Follow me on Twitter